457 related articles for article (PubMed ID: 34415486)
21. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
22. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
[TBL] [Abstract][Full Text] [Related]
23. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
[TBL] [Abstract][Full Text] [Related]
24. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
25. Regulation of beta-amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds.
Qiu W; Liu H; Liu Y; Lu X; Wang L; Hu Y; Feng F; Li Q; Sun H
Med Res Rev; 2023 Jul; 43(4):1091-1140. PubMed ID: 36945751
[TBL] [Abstract][Full Text] [Related]
26. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
[TBL] [Abstract][Full Text] [Related]
27. Treatment with the neurotoxic Aβ (25-35) peptide modulates the expression of neuroprotective factors Pin1, Sirtuin 1, and brain-derived neurotrophic factor in SH-SY5Y human neuroblastoma cells.
Lattanzio F; Carboni L; Carretta D; Candeletti S; Romualdi P
Exp Toxicol Pathol; 2016 May; 68(5):271-6. PubMed ID: 26915812
[TBL] [Abstract][Full Text] [Related]
28. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
29. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives.
Cheng Y; Tian DY; Wang YJ
Transl Neurodegener; 2020 May; 9(1):16. PubMed ID: 32381118
[TBL] [Abstract][Full Text] [Related]
30. The effects of treadmill exercise on autophagy in hippocampus of APP/PS1 transgenic mice.
Zhao N; Zhang X; Song C; Yang Y; He B; Xu B
Neuroreport; 2018 Jul; 29(10):819-825. PubMed ID: 29672446
[TBL] [Abstract][Full Text] [Related]
31. The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease.
Amidfar M; de Oliveira J; Kucharska E; Budni J; Kim YK
Life Sci; 2020 Sep; 257():118020. PubMed ID: 32603820
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
Gandy S; Petanceska S
Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
[TBL] [Abstract][Full Text] [Related]
34. Total flavonoid extract from Dracoephalum moldavica L. attenuates β-amyloid-induced toxicity through anti-amyloidogenesic and neurotrophic pathways.
Liu QS; Jiang HL; Wang Y; Wang LL; Zhang JX; He CH; Shao S; Zhang TT; Xing JG; Liu R
Life Sci; 2018 Jan; 193():214-225. PubMed ID: 29100755
[TBL] [Abstract][Full Text] [Related]
35. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
[TBL] [Abstract][Full Text] [Related]
36. Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation.
Son SM; Shin HJ; Byun J; Kook SY; Moon M; Chang YJ; Mook-Jung I
J Alzheimers Dis; 2016; 51(4):1197-208. PubMed ID: 26967226
[TBL] [Abstract][Full Text] [Related]
37. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
[TBL] [Abstract][Full Text] [Related]
38. Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.
Babalola JA; Lang M; George M; Stracke A; Tam-Amersdorfer C; Itxaso I; Lucija D; Tadic J; Schilcher I; Loeffler T; Flunkert S; Prokesch M; Leitinger G; Lass A; Hutter-Paier B; Panzenboeck U; Hoefler G
Brain Res; 2023 Nov; 1819():148518. PubMed ID: 37579986
[TBL] [Abstract][Full Text] [Related]
39. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
40. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]